## CLX: The Clorox Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.6% below STRENGTH zone (4.0-10.0%); PEG 3.19 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($96.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. VIRGINIA RETIREMENT SYSTEMS ET Al Acquires 449,000 Shares of The Clorox Company $CLX**
- Source: MarketBeat | 20251231T115832 | Neutral | Relevance: 100%
- Virginia Retirement Systems increased its stake in The Clorox Company by buying an additional 449,000 shares, bringing its total to 450,800 shares valued at approximately $55.6 million. Other institutional investors like Invesco and Norges Bank also significantly increased their positions, leading to institutional investors owning about 78.53% of Clorox stock. Despite beating quarterly EPS estimates, Clorox reported an 18.9% year-over-year revenue decrease and has a "Reduce" consensus analyst rating.

**2. Boston Trust Walden Corp Sells 304,102 Shares of The Clorox Company $CLX**
- Source: MarketBeat | 20251231T094843 | Neutral | Relevance: 100%
- Boston Trust Walden Corp significantly reduced its stake in The Clorox Company ($CLX) by selling 304,102 shares in Q3, retaining only 3,048 shares. This comes as Clorox reported a Q3 EPS of $0.85, beating estimates, but revenue decreased by 18.9% year-over-year. Insider activity includes Director Pierre R. Breber acquiring 4,000 shares, increasing his ownership to 13,000 shares.

**3. Albion Financial Group UT Trims Stock Holdings in The Clorox Company $CLX**
- Source: MarketBeat | 20251231T084803 | Somewhat-Bearish | Relevance: 100%
- Albion Financial Group UT significantly reduced its stake in The Clorox Company ($CLX) by 99.1% in the third quarter, selling 34,585 shares and retaining only 304 shares. This divestment contrasts with major institutional investors like Vanguard, Invesco, and Norges Bank, which increased or initiated large positions in CLX. Analysts have a cautious outlook, with an average "Reduce" rating and several firms lowering price targets.

**4. My 3 Favorite Stocks to Buy Right Now**
- Source: The Globe and Mail | 20251231T183658 | Somewhat-Bullish | Relevance: 73%
- An investor details strategic tax-loss harvesting by selling Hormel and Clorox, with plans to repurchase them in early 2026, while concurrently adding to General Mills. The article highlights these three consumer staples companies as favorites due to their historically high dividend yields and reliable performance despite current industry headwinds. The author emphasizes a long-term investment approach to benefit from temporary market downturns in the consumer staples sector.

**5. P&G stock slips on the year-end close — what to watch before Procter & Gamble’s Jan. 22 earnings**
- Source: ts2.tech | 20260101T014310 | Neutral | Relevance: 63%
- Procter & Gamble (PG) stock fell 0.5% to $143.31 on the last trading day of 2025, amidst a broader market decline, ahead of key events including a CEO change on January 1st and the company's Q1 earnings report on January 22nd. Investors will be watching for updates on sales volumes, pricing, promotions, and input costs, as well as the new CEO's priorities on growth and capital returns. The article also highlights upcoming economic data releases in early January that could influence consumer staples valuations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $109 | $120 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.42M) |
| Sells | 7 ($0.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.2x requires aggressive growth execution.
2. Long-term trend broken: trading 17.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +4.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.19 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.3B |
| Beta | 0.57 |
| 52W Range | $96.66 - $164.22 |
| Short Interest | 6.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.19 |
| Forward P/E | 14.9 |
| Current P/E | 16.9 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.3% to 0.6% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >4.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 46. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.59% (CS: 47) | Neutral |
| RSI_14 | 45.7 | Neutral |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 0.821x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $100.85
- **Stop Loss:** $96.91 (3.9% risk)
- **Target:** $104.79 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 304
- **Position Value:** $30,658.40
- **Portfolio %:** 30.66%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*